Preliminary results of a phase 1 study of a third-generation selective estrogen receptor modulator (SERM3, LY353381.HC1) in refractory, metastatic breast cancer Meeting Abstract
| Authors: | Hudis, C.; Buzdar, A.; Munster, P.; Booser, D.; Seidman, A.; Theriault, R.; Moasser, M.; Frye, D.; Surbone, A.; Major, M.; Dhingra, K.; Norton, L. |
| Abstract Title: | Preliminary results of a phase 1 study of a third-generation selective estrogen receptor modulator (SERM3, LY353381.HC1) in refractory, metastatic breast cancer |
| Meeting Title: | 16th Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow |
| Keywords: | meeting abstract |
| Journal Title: | Cancer Investigation |
| Volume: | 17 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 1998 Nov 11-13 |
| Meeting Location: | New York, NY |
| ISSN: | 0735-7907 |
| Publisher: | Informa Healthcare |
| Date Published: | 1999-01-01 |
| Start Page: | 51 |
| End Page: | 52 |
| Language: | English |
| ACCESSION: | BCI:BCI199900163199 |
| PROVIDER: | biosis |
| PUBMED: | 10083854 |
| Notes: | Meeting abstract: 43 -- Chemotherapy Foundation -- Source: Biosis |
Citation Impact
Related MSK Work